Reduced Expression of Pten and Increased Pten Phosphorylation at Residue Ser380 in Gastric Cancer Tissues: A Novel Mechanism of Pten Inactivation

Zhen Yang,Xiao-Gang Yuan,Jiang Chen,Shi-Wen Luo,Zhi-Jun Luo,Nong-Hua Lu
DOI: https://doi.org/10.1016/j.clinre.2012.03.002
IF: 3.189
2013-01-01
Clinics and Research in Hepatology and Gastroenterology
Abstract:Aim: PTEN is a tumor suppressor gene in different cancers. This study was to determine the protein expression of PTEN and phosphorylation of PTEN (p-PTEN) at residue Ser380 in different histology specimens of gastric tissues.Methods: A total of 179 tissue specimens of normal gastric mucosa, chronic gastritis, intestinal metaplasia, dysplasia, and gastric cancer were recruited for immunohistochemical analysis of PTEN and p-PTEN expression. Four gastric cancer AGS, MKN-45, MKN-28, and SGC-7901 cell lines and a non-cancerous gastric GES-1 cell line were used to detect expression of PTEN and p-PTEN protein using Western blot.Results: Expression level of PTEN protein was significantly decreased in gastric cancer tissues compared to normal gastric mucosa, chronic gastritis, intestinal metaplasia and dysplasia (P < 0.05). In contrast, p-PTEN protein level was significantly increased in intestinal metaplasia, dysplasia and gastric cancer compared to normal gastric mucosa and chronic gastritis (P < 0.05). However, there was no any association of PTEN and p-PTEN expression with clinicopathological characteristics from gastric cancer patients. Moreover, the ratio of p-PTEN and PTEN was higher in gastric cancer cell lines than that of the non-malignant cells.Conclusions: This study demonstrated that aberrant expression of PTEN and p-PTEN at residue Ser380 was early event that could contribute to gastric carcinogenesis, and that PTEN phosphorylation at residue Ser380 could be a mechanism for PTEN inactivation. (C) 2012 Elsevier Masson SAS. All rights reserved.
What problem does this paper attempt to address?